Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Evopoint Biosciences Inc.
Evopoint Biosciences Inc.
Bristol-Myers Squibb
Radiopharm Theranostics, Ltd
Terremoto Biosciences Inc.
GI Innovation, Inc.
Ensem Therapeutics
Mayo Clinic
Eli Lilly and Company
Neonc Technologies, Inc.
Rutgers, The State University of New Jersey
Sichuan Enray Pharmaceutical Sciences Company
Theravectys S.A.
Grey Wolf Therapeutics
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Washington University School of Medicine
Tanabe Pharma America, Inc.
DualityBio Inc.
University of Arizona
Sichuan Baili Pharmaceutical Co., Ltd.
LigaChem Biosciences, Inc.
Yuhan Corporation
University of California, Irvine
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Precision Biologics, Inc
Tianjin Medical University Cancer Institute and Hospital
Cancer Research UK
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
GeneMedicine Co., Ltd.
Evopoint Biosciences Inc.